Pannus in Dogs: The Science Behind Chronic Superficial Keratitis
Learn the science behind pannus in dogs — causes, immune mechanisms, breed risks, UV triggers, treatment costs, and how to protect your dog's vision long-term.
What Is Pannus in Dogs?
Pannus (chronic superficial keratitis) is an immune-mediated eye disease in dogs where blood vessels, scar tissue, and dark pigment invade the cornea — typically starting at the outer (lateral) edge and progressing inward. If left untreated, it can cause significant vision loss or blindness. It is not contagious, not caused by infection, and not the result of trauma. The condition is driven by an abnormal immune response against the dog's own corneal tissue, amplified by ultraviolet (UV) light exposure. German Shepherds and related breeds are disproportionately affected due to inherited immune system dysregulation. While there is no cure, lifelong management with topical immunosuppressive medications (cyclosporine, tacrolimus, or corticosteroids) controls the disease in most dogs, with annual treatment costs typically ranging from $300 to $1,200 depending on severity and medication choice.
The Immunology of Pannus: How a Dog's Own Defense System Attacks the Eye
The Physiological Mechanism
Pannus is classified as an immune-mediated disease — meaning the dog's immune system mistakenly identifies normal corneal tissue as a threat. Here is the step-by-step pathology:
- Initial trigger: UV radiation damages superficial corneal cells, altering surface proteins (antigens) on the corneal epithelium and stroma.
- Immune recognition failure: T-lymphocytes (specifically CD4+ helper T cells) fail to recognize these UV-altered proteins as "self." This breakdown in immune tolerance is the core defect.
- Inflammatory cascade: Activated T cells recruit plasma cells and additional lymphocytes to the limbus (the border between the cornea and sclera). These cells release inflammatory cytokines including interleukin-2 (IL-2) and interferon-gamma (IFN-γ).
- Neovascularization: Inflammatory mediators stimulate vascular endothelial growth factor (VEGF), causing new blood vessels to grow from the limbus onto the normally avascular cornea. This is the hallmark "fleshy, pink" appearance owners first notice.
- Fibrosis and pigmentation: Chronic inflammation triggers fibroblast proliferation (scar tissue) and melanocyte migration (dark pigment deposition). Over months to years, this opaque tissue spreads across the corneal surface, obstructing light entry to the retina.
The reason the lateral (outer) cornea is affected first relates to the anatomy of the canine eye: the lateral limbus receives more direct UV exposure due to less protection from the brow and eyelid structures compared to the nasal side.
According to the Merck Veterinary Manual, the infiltrate in pannus consists predominantly of lymphocytes and plasma cells, confirming the cell-mediated (Type IV hypersensitivity) immune mechanism. Research published in the Veterinary Ophthalmology journal has demonstrated that German Shepherds with pannus show significantly altered major histocompatibility complex (MHC) class II gene expression, suggesting a heritable component to the immune dysregulation rather than purely environmental causation.
Why German Shepherds: The Evolutionary and Genetic Context
Ancestral Immune System Trade-Offs
The immune system dysregulation that predisposes certain breeds to pannus is, in evolutionary terms, an unintended consequence of selective breeding for heightened immune vigilance. In ancestral wolves and early working dogs, a robust, aggressive immune response was advantageous — it protected against parasites, bacterial infections, and environmental pathogens encountered during hunting and territorial patrol.
German Shepherds were specifically developed in late 19th-century Germany as versatile herding and protection dogs. Breeding prioritized dogs with strong environmental awareness, physical resilience, and reactive immune systems capable of handling the demands of outdoor farm and police work. The same MHC gene variants that made these dogs excellent at fighting off infections also made them more prone to autoimmune conditions where the immune system turns on the body's own tissues.
This is a classic example of antagonistic pleiotropy — a genetic principle where a gene that provides one advantage (strong pathogen defense) simultaneously creates a vulnerability (autoimmune disease). Pannus is essentially the immune system doing its job too well, in the wrong location.
German Shepherds are not the only breed affected. The inherited predisposition extends to related breeds and those sharing similar MHC profiles. Here is the breed risk breakdown based on veterinary ophthalmology case data:
| Risk Level | Breeds | Notes |
|---|---|---|
| Highest | German Shepherd, Belgian Tervuren | Account for majority of cases; often presents at younger age (3–5 years) |
| High | Belgian Malinois, Belgian Sheepdog (Groenendael), Border Collie | Shared herding-dog lineage and MHC profiles |
| Moderate | Australian Shepherd, Siberian Husky, Greyhound | Reported cases but lower prevalence; often later onset |
| Low/Occasional | Labrador Retriever, mixed breeds, other breeds | Can occur in any breed, especially at high altitude or with heavy UV exposure |
How Dogs Process UV Damage to the Eye — and How It Differs from Humans
Understanding why pannus develops requires understanding how canine eyes handle UV radiation differently from human eyes.
In humans, the cornea absorbs most UVB radiation (280–315 nm), and the lens absorbs most UVA (315–400 nm). The human cornea has a relatively robust DNA repair mechanism, and conditions like pterygium (the closest human analogue to pannus) develop over decades of chronic sun exposure, typically in equatorial populations.
In dogs, several anatomical and physiological differences increase vulnerability:
- Lens transmission: Unlike humans, the canine lens transmits more UVA light to the retina. However, the cornea still absorbs significant UVB, and it is this UVB damage at the limbus that triggers the initial immune response in pannus.
- Less brow protection: Many affected breeds (German Shepherds, Belgian breeds) have relatively flat facial profiles with less prominent brow ridges compared to brachycephalic breeds, leaving the lateral cornea more exposed to overhead and reflected UV.
- Outdoor lifestyle selection: Herding and working breeds were historically selected for all-day outdoor activity, meaning cumulative UV dose to the eye is substantially higher than in indoor-oriented breeds.
- Immune threshold: The inherited MHC variants in predisposed breeds mean the threshold for triggering an autoimmune response against UV-damaged corneal cells is lower — it takes less UV damage to initiate the cascade.
This is why altitude matters enormously. Dogs living at elevations above 5,000 feet (approximately 1,500 meters) receive roughly 20–30% more UV radiation than those at sea level. Veterinary ophthalmologists in Colorado, Utah, and the Mountain West states report significantly higher pannus prevalence and faster progression rates — a phenomenon well-documented in veterinary literature and sometimes referred to colloquially as "Colorado pannus" or "high-altitude pannus."
Recognizing Pannus: What the Signs Mean and When They Signal a Problem
Early detection is critical because corneal changes from pannus are irreversible — treatment can halt progression and reduce active inflammation, but existing scar tissue and pigment will not fully resolve. Here is how the disease progresses through observable stages:
| Stage | What You See | What's Happening Biologically | Urgency |
|---|---|---|---|
| Early (Stage 1) | Faint pink or flesh-colored film at the outer corner of one or both eyes; slight redness at the edge of the cornea | Initial lymphocytic infiltration at lateral limbus; early neovascularization | Schedule vet appointment within 1–2 weeks |
| Progressive (Stage 2) | Visible blood vessels extending onto cornea; pink/gray tissue spreading inward; mild cloudiness | Active neovascularization and fibroblast proliferation; inflammatory cytokines elevated | Vet visit within 1 week; start treatment promptly |
| Advanced (Stage 3) | Dark brown/black pigment covering significant corneal area; thickened, opaque tissue; visible vision impairment (bumping into objects, hesitation in dim light) | Melanocyte migration and dense fibrosis; corneal opacity blocking light transmission to retina | Urgent — veterinary ophthalmologist referral recommended |
| End-stage (Stage 4) | Cornea fully covered in pigment and scar tissue; functional blindness in affected eye(s) | Complete corneal opacification; retinal function may be intact but light cannot reach it | Ongoing management; surgical options may be discussed |
⚠️ When to Call the Vet Immediately
Contact your veterinarian or a veterinary ophthalmologist today if you observe any of the following:
- Sudden squinting, pawing at the eye, or holding the eye closed (may indicate corneal ulceration secondary to pannus treatment or a concurrent condition)
- Rapid change in eye appearance over 24–48 hours
- Visible third eyelid swelling or prolapse (pannus can also affect the third eyelid — a variant called "atypical pannus" or "plasma cell conjunctivitis")
- Cloudiness or blue haze across the entire cornea (may indicate corneal edema or uveitis, which require different treatment)
- Any eye changes in a German Shepherd, Belgian Tervuren, or related breed — even subtle ones warrant professional evaluation
Always consult your veterinarian for diagnosis and treatment planning. This article provides educational information and does not replace professional veterinary care.
Pannus Treatment: Medications, Costs, and Long-Term Management
Because pannus is immune-mediated — not infectious — treatment focuses on suppressing the local immune response at the corneal surface. The goal is to halt progression, reduce active inflammation, and preserve remaining vision. Here is a comparison of the primary treatment options:
| Medication | Mechanism | Typical Dosing | Annual Cost Range | Notes |
|---|---|---|---|---|
| Cyclosporine ophthalmic (Optimmune® 0.2%, compounded 1–2%) | Calcineurin inhibitor; suppresses T-cell activation and IL-2 production | 1 drop per affected eye, 2× daily (maintenance); may increase to 3× daily during flares | $250–$600 (brand name); $150–$350 (compounded) | First-line treatment for most cases; well-tolerated long-term |
| Tacrolimus ophthalmic (compounded 0.02–0.03%) | Calcineurin inhibitor; 10–100× more potent than cyclosporine at T-cell suppression | 1 drop per affected eye, 2× daily | $300–$700 (compounded) | Used when cyclosporine alone is insufficient; excellent for pigment-predominant cases |
| Dexamethasone or prednisolone ophthalmic | Corticosteroid; broad anti-inflammatory and immunosuppressive action | 1 drop per affected eye, 2–4× daily initially, then tapered | $80–$200 | Used for acute flare-ups; NOT for long-term monotherapy due to risks (cataracts, glaucoma, corneal ulceration) |
| Subconjunctival corticosteroid injection | Depot steroid (e.g., triamcinolone) injected under the conjunctiva for sustained local release | Single injection, repeated every 3–6 months as needed | $150–$400 per injection (including exam) | Option for dogs difficult to medicate topically; performed under sedation |
| Strontium-90 beta radiation / surgical keratectomy | Removes or destroys pigmented/scarred corneal tissue | Single procedure; followed by medical management | $800–$2,500 | Reserved for advanced cases with significant vision loss; performed by veterinary ophthalmologist |
UV protection is a non-negotiable adjunct to medication. Even with perfect medication compliance, ongoing UV exposure will continue to drive the immune response. Practical UV reduction strategies include:
- Doggles or Rex Specs canine sunglasses: UV-blocking goggles designed for dogs ($30–$80). Not all dogs tolerate them, but positive reinforcement training (treat-pairing, short sessions) gets most dogs accustomed within 2–4 weeks.
- Avoid peak UV hours: Walk dogs before 10 AM and after 4 PM when UV index is lower, especially in summer and at altitude.
- Shade access: Ensure outdoor time includes shaded areas; UV-reflective surfaces (sand, snow, light concrete) increase exposure even in shade.
Common Misconceptions About Pannus Debunked
| Myth | Fact |
|---|---|
| "Pannus is an eye infection — antibiotics will fix it." | Pannus is autoimmune, not infectious. Antibiotics have no role in treatment. The inflammation is driven by T-cell dysregulation, not bacteria or viruses. |
| "It only happens to old dogs." | While pannus most commonly appears between ages 4–7, it can onset as early as 1–2 years in highly predisposed breeds like German Shepherds. Age is a risk factor, not a requirement. |
| "If I keep my dog indoors, they won't get pannus." | UVA penetrates glass windows. While indoor living reduces risk, genetically predisposed dogs can still develop pannus from ambient UV exposure during walks, yard time, and car rides. Genetic predisposition is the primary driver. |
| "Once the eye looks better, I can stop the medication." | Pannus is a lifelong condition requiring lifelong management. Stopping medication allows the immune response to reactivate, often aggressively. Most dogs require at least once-daily topical treatment for life, though frequency may decrease during low-UV seasons. |
| "Pannus is painful for my dog." | In most cases, pannus is not painful — it is a slow, insidious process. Dogs typically do not squint or paw at the eye unless a secondary complication (corneal ulcer, dry eye) is present. This lack of pain is exactly why owners often miss early signs. |
| "Pannus is contagious to other dogs or humans." | Pannus is not transmissible. It is an autoimmune condition with genetic and environmental (UV) triggers. Multi-dog households have no cross-infection risk. |
Related Eye Conditions: What Else Could It Be?
Several other canine eye conditions share overlapping symptoms with pannus. Understanding the differences helps you communicate effectively with your veterinarian:
- Dry eye (keratoconjunctivitis sicca, KCS): Also immune-mediated and common in similar breeds, KCS causes thick mucoid discharge and a dull, dry corneal surface rather than the vascularized, fleshy growth of pannus. However, KCS and pannus can co-occur, and chronic dry eye can produce secondary corneal pigmentation that mimics pannus. A Schirmer tear test (measuring tear production in mm/min — normal is ≥15 mm/min) differentiates the two.
- Pigmentary keratitis (brachycephalic breeds): Pugs, Shih Tzus, and Bulldogs develop corneal pigmentation due to chronic irritation from facial folds, incomplete blink coverage, and medial entropion — not an autoimmune mechanism. The pigment typically starts at the nasal cornea (opposite of pannus, which starts laterally).
- Corneal dystrophy: An inherited condition causing crystalline or opaque deposits within the corneal stroma. Unlike pannus, corneal dystrophy does not involve blood vessel growth and is not driven by UV exposure or immune dysfunction.
- Pannus of the third eyelid (atypical pannus): A variant where the depigmentation and swelling affects the nictitating membrane (third eyelid) rather than the cornea. The third eyelid appears thickened, pale, and depigmented. Treatment is similar to classic pannus. This variant is particularly common in German Shepherds and is sometimes called "plasma cell conjunctivitis" or "nodular granulomatous episclerokeratitis."
Frequently Asked Questions About Pannus in Dogs
Is pannus in dogs normal?
No — pannus is a pathological immune-mediated disease, not a normal aging change. While it is common in certain breeds (particularly German Shepherds), "common" does not mean "normal." Any corneal vascularization, pigment, or tissue growth warrants veterinary evaluation. Normal age-related changes in the canine eye include nuclear sclerosis (a bluish-gray haze in the lens that does not significantly impair vision) and iris atrophy — neither of which involves the corneal surface.
Can dogs go blind from pannus?
Yes, if pannus is left untreated or inadequately managed, progressive corneal pigmentation and scarring can lead to functional blindness. However, with early diagnosis and consistent lifelong medication, most dogs retain functional vision throughout their lives. The key variable is treatment compliance — dogs whose owners apply medication consistently and maintain UV protection have significantly better long-term outcomes. A study of cyclosporine-treated pannus cases reported stabilization or improvement in over 85% of dogs with consistent treatment.
Why do dogs get pannus — is it genetic or environmental?
Both. Pannus results from a gene-environment interaction. The genetic component involves inherited MHC class II variants that predispose the immune system to corneal autoimmunity. The environmental trigger is UV radiation, which damages corneal proteins and initiates the immune cascade. A genetically predisposed dog kept entirely indoors with zero UV exposure may never develop pannus; a non-predisposed dog at extreme altitude with heavy UV exposure might develop a mild form. The highest risk occurs when genetic susceptibility and significant UV exposure overlap.
How is pannus diagnosed? What tests will the vet run?
Diagnosis is primarily based on clinical appearance and breed history. Your veterinarian or veterinary ophthalmologist will typically perform: a complete ophthalmic exam with slit-lamp biomicroscopy, a Schirmer tear test (to rule out concurrent KCS), fluorescein staining (to rule out corneal ulcers before starting corticosteroids), and intraocular pressure measurement (tonometry, to rule out glaucoma). In atypical cases, a conjunctival biopsy may be performed to confirm the lymphocytic-plasmacytic infiltrate. Total diagnostic workup typically costs $150–$400 at a general practice or $300–$600 at a veterinary ophthalmology specialist.
Can I use human eye drops for my dog's pannus?
No. Human ophthalmic preparations may contain preservatives, concentrations, or active ingredients that are inappropriate or harmful for canine eyes. Additionally, the specific formulations and concentrations needed for pannus management (compounded cyclosporine at 1–2%, tacrolimus at 0.02–0.03%) are not available as over-the-counter human products. Your veterinarian will prescribe veterinary-specific or compounded formulations at the correct concentration. Using the wrong medication — particularly corticosteroid drops in a dog with an undiagnosed corneal ulcer — can cause rapid corneal melting and perforation within 48–72 hours.
What does it mean when my German Shepherd's eyes are turning brown?
Brown discoloration on the corneal surface (not the iris) in a German Shepherd is highly suggestive of pannus-related pigment deposition. This represents an advanced stage of the disease where melanocytes have migrated into the corneal tissue in response to chronic inflammation. If you are noticing this change, schedule a veterinary ophthalmology appointment promptly. If the brown discoloration is on the iris (the colored part inside the eye) rather than the corneal surface, this may be iris melanosis or an iris melanoma — a different condition entirely that also requires veterinary evaluation.
Practical Takeaways for Dog Owners
Your Pannus Management Checklist
- Know your breed's risk: If you own a German Shepherd, Belgian Tervuren, Belgian Malinois, Border Collie, or Australian Shepherd, have your dog's eyes examined annually by a veterinarian — even if no symptoms are visible.
- Learn the early signs: Check your dog's eyes monthly in good lighting. Look for faint pink or flesh-colored tissue at the outer corners of the cornea. Photograph both eyes monthly for comparison.
- Budget for lifelong treatment: Expect $300–$1,200 annually for medication, plus $150–$400 for biannual recheck exams. Over a 10-year treatment period, total costs range from $4,500 to $16,000. Pet insurance may cover pannus if diagnosed after the policy's waiting period — but pre-existing conditions are excluded.
- Invest in UV protection: UV-blocking canine goggles ($30–$80) and strategic scheduling of outdoor activity are as important as medication in slowing disease progression.
- Never stop medication without veterinary guidance: Even if the eyes look clear, the immune dysregulation persists. Medication dose reduction should only occur under veterinary supervision, typically during low-UV winter months.
- Consider specialist referral: For advanced cases, a board-certified veterinary ophthalmologist (DACVO) offers advanced options including subconjunctival injections, beta-radiation therapy, and surgical keratectomy. Find one through the American College of Veterinary Ophthalmologists.
This article is for educational purposes and does not replace professional veterinary advice. If you suspect your dog has pannus or any eye condition, consult your veterinarian promptly. Early intervention preserves vision.
Jonas Cole
All our authors care for dogs every day — read more of their work on the authors page.
